Via: GlobeNewsWire
SUNNYVALE, Calif., July 09, 2020 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that Andrew Davis has been promoted to Chief Commercial Officer.
In this newly created role, Mr. Davis will oversee Silk Road Medical’s global commercialization efforts. Mr. Davis joined Silk Road Medical as the company’s first commercial leader in 2015 and has successfully built the sales team to over 100 customer facing field members, achieving over $125 million in cumulative revenue. As Chief Commercial Officer, Mr. Davis is an integral member of the executive team responsible for establishing near term priorities and setting the long-term strategic direction for the company.
“Andy and his team have had a monumental role in our commercial success driving the safe adoption of TCAR across the U.S.,” said Erica Rogers, Chief Executive Officer. “His contributions to the development of our sales team and commercial strategy have been vital to our organization. In his new role, we are confident that Andy will provide additional strategic direction and value and deliver meaningful and lasting results for Silk Road Medical.”
Read More: https://www.globenewswire.com/news-release/2020/07/09/2060262/0/en/Silk-Road-Medical-Promotes-Andrew-Davis-to-Newly-Created-Position-of-Chief-Commercial-Officer.html#:~:text=(Nasdaq%3A%20SILK)%2C%20a,Road%20Medical's%20global%20commercialization%20efforts.
RSS Feed
